VTEX

NYSE:VTEX

4.77 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 61.52455.99656.54152.64860.72150.62847.88642.28245.48538.75438.71434.66737.11631.86430.86925.92429.10727.65225.27516.642
Cost of Revenue 15.45814.27816.03715.87315.85715.0215.50614.56614.59412.62713.00812.60313.7612.79112.21810.82311.8588.7757.486.738
Gross Profit 46.06641.71840.50436.77544.86435.60832.3827.71630.89126.12725.70622.06423.35619.07318.65115.10117.24918.87717.7959.904
Gross Profit Ratio 0.7490.7450.7160.6990.7390.7030.6760.6560.6790.6740.6640.6360.6290.5990.6040.5830.5930.6830.7040.595
Reseach & Development Expenses 13.2913.36614.23612.72814.34415.50816.30513.95914.05913.81215.40913.92511.91514.17910.6698.4236.8274.5123.6384.062
General & Administrative Expenses 8.098.4028.7679.1729.1328.3748.2427.9257.0526.9447.4316.9216.9139.9477.8067.2235.123.3362.4023.103
Selling & Marketing Expenses 17.00816.4117.25217.19215.12915.10114.44914.78212.40416.17621.31817.917.45919.3315.69711.0357.4885.255.365.746
SG&A 25.09824.81224.90425.25124.26123.47522.69122.70719.45623.1228.74924.82124.37229.27723.50318.25812.6088.5867.7628.849
Other Expenses 0.5520.668-0.33100000.7540.4020.4890.474-0.0080.211-0.0140.8680.449-0.1230.2750.2630.047
Operating Expenses 38.9438.84639.1437.97939.16139.08239.50737.4233.91737.42144.63238.73836.49843.44235.0427.1319.31213.37311.66312.958
Operating Income 7.1262.8721.364-1.2045.703-3.474-7.127-9.7043.728-11.294-18.926-16.674-13.142-24.369-16.389-12.029-2.0635.5046.132-3.054
Operating Income Ratio 0.1160.0510.024-0.0230.094-0.069-0.149-0.230.082-0.291-0.489-0.481-0.354-0.765-0.531-0.464-0.0710.1990.243-0.184
Total Other Income Expenses Net 0.761-0.62.775-3.3760.3781.3590.4811.7973.0530.082-5.158-4.502-1.179-0.404-1.215-1.259-1.274-0.5451.57-2.807
Income Before Tax 7.8872.2724.47-4.9666.081-2.115-6.646-7.9070.027-11.212-24.084-21.176-14.321-24.773-17.604-13.288-3.3374.9597.702-5.861
Income Before Tax Ratio 0.1280.0410.079-0.0940.1-0.042-0.139-0.1870.001-0.289-0.622-0.611-0.386-0.777-0.57-0.513-0.1150.1790.305-0.352
Income Tax Expense 1.611-0.972-0.459-2.5122.8580.264-0.0360.0210.3490.33-2.619-2.085-3.696-2.814-2.135-0.8270.931.9812.04-0.663
Net Income 6.2643.2454.935-2.4463.226-2.374-6.611-7.928-0.322-11.542-21.465-19.091-10.625-21.959-15.469-12.458-4.272.9395.619-5.202
Net Income Ratio 0.1020.0580.087-0.0460.053-0.047-0.138-0.188-0.007-0.298-0.554-0.551-0.286-0.689-0.501-0.481-0.1470.1060.222-0.313
EPS 0.0340.0180.027-0.0130.018-0.013-0.035-0.042-0.002-0.061-0.11-0.1-0.056-0.12-0.083-0.067-0.0230.0160.03-0.028
EPS Diluted 0.0330.0170.026-0.0130.018-0.013-0.035-0.042-0.002-0.061-0.11-0.1-0.056-0.12-0.083-0.067-0.0230.0160.03-0.028
EBITDA 9.0063.4572.479-3.5977.908-0.484-5.1142.60310.427-9.501-16.969-14.944-12.979-20.768-13.872-10.608-6.4737.1496.467-4.647
EBITDA Ratio 0.1460.0620.044-0.002-0.2480.0560.078-0.0180.109-0.07-0.332-0.319-0.381-0.647-0.424-0.453-0.2220.2670.372-0.142